These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 7536170)
1. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats. Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170 [TBL] [Abstract][Full Text] [Related]
2. Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes. Grønbaek H; Vogel I; Osterby R; Lancranjan I; Flyvbjerg A; Orskov H Kidney Int; 1998 Jan; 53(1):173-80. PubMed ID: 9453015 [TBL] [Abstract][Full Text] [Related]
3. Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion. Flyvbjerg A; Marshall SM; Frystyk J; Hansen KW; Harris AG; Orskov H Kidney Int; 1992 Apr; 41(4):805-12. PubMed ID: 1513103 [TBL] [Abstract][Full Text] [Related]
4. [Octreotide suppresses the kidney weight and glomerular hypertrophy in diabetic rats]. Iwasaki S Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):247-55. PubMed ID: 8501854 [TBL] [Abstract][Full Text] [Related]
5. The calcium channel blocker nitrendipine attenuates renal and glomerular hypertrophy in diabetic rats. Nielsen B; Gronbaek H; Osterby R; Orskov H; Flyvbjerg A Exp Nephrol; 1999; 7(3):242-50. PubMed ID: 10352365 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice. Grønbaek H; Nielsen B; Schrijvers B; Vogel I; Rasch R; Flyvbjerg A J Endocrinol; 2002 Mar; 172(3):637-43. PubMed ID: 11874712 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Flyvbjerg A; Bennett WF; Rasch R; Kopchick JJ; Scarlett JA Diabetes; 1999 Feb; 48(2):377-82. PubMed ID: 10334317 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of renal ornithine decarboxylase activity fails to reduce kidney size and urinary albumin excretion in diabetic rats with manifest kidney hypertrophy. Pedersen SB; Bjørn SF; Richelsen B; Flyvbjerg A Mol Cell Endocrinol; 1995 Jan; 107(1):123-8. PubMed ID: 7796931 [TBL] [Abstract][Full Text] [Related]
9. Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention. Grønbaek H; Nielsen B; Frystyk J; Orskov H; Flyvbjerg A J Endocrinol; 1995 Oct; 147(1):95-102. PubMed ID: 7490542 [TBL] [Abstract][Full Text] [Related]
10. Long-term effects of a somatostatin analogue on renal haemodynamics and hypertrophy in diabetic rats. Muntzel M; Hannedouche T; Niesor R; Nöel LH; Souberbielle JC; Lacour B; Drüeke T Clin Sci (Lond); 1992 Nov; 83(5):575-81. PubMed ID: 1335394 [TBL] [Abstract][Full Text] [Related]
11. Effect of nitrendipine and nisoldipine on renal structure and function in long-term experimental diabetes in rats. Nielsen B; Grønbaek H; Osterby R; Flyvbjerg A Am J Kidney Dis; 2000 Aug; 36(2):368-77. PubMed ID: 10922316 [TBL] [Abstract][Full Text] [Related]
12. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023 [TBL] [Abstract][Full Text] [Related]
13. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats. Raz I; Rubinger D; Popovtzer M; Grønbaek H; Weiss O; Flyvbjerg A Diabetes; 1998 Jun; 47(6):924-30. PubMed ID: 9604870 [TBL] [Abstract][Full Text] [Related]
14. Octreotide administration in diabetic rats: effects on renal function and morphology. Usenmez T; Yildiz O; Oktenli C; Ozgurtas T; Kutlu M J Diabetes Complications; 2000; 14(1):53-9. PubMed ID: 10925067 [TBL] [Abstract][Full Text] [Related]
15. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats. Wienen W; Richard S; Champeroux P; Audeval-Gerard C J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):31-6. PubMed ID: 11881063 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats. Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365 [TBL] [Abstract][Full Text] [Related]
17. Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition. New JP; Canavan JP; Flyvbjerg A; Hamon G; Bilous RW; Marshall SM Diabetologia; 1996 Feb; 39(2):166-71. PubMed ID: 8635668 [TBL] [Abstract][Full Text] [Related]
18. Renal-protective effect of nondepressor dose of cicletanine in diabetic rats with hypertension. Kohzuki M; Wu XM; Kamimoto M; Yoshida K; Nagasaka M; Kanazawa M; Yasujima M; Saito T; Sato T Am J Hypertens; 2000 Mar; 13(3):298-306. PubMed ID: 10777035 [TBL] [Abstract][Full Text] [Related]
19. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Sjöquist M Kidney Int; 2001 Oct; 60(4):1258-65. PubMed ID: 11576340 [TBL] [Abstract][Full Text] [Related]
20. Effect of lanreotide on local kidney IGF-I and renal growth in experimental diabetes in the rat. Grønbaek H; Nielsen B; Frystyk J; Flyvbjerg A; Orskov H Exp Nephrol; 1996; 4(5):295-303. PubMed ID: 8931985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]